EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut‐Kidney Axis Restoration and TLR4/NF‐ κ B/NLRP3 Suppression

Yuxin Wang iD, Pei Sheng iD, Xue Wang iD, Min Lin iD, Wentao Cai iD, Shiyao Wei iD, Yuyun Du iD, Ming Yan iD, Lei Wang iD, Xiaofei An iD

Journal of Diabetes Research · 2026-01 · 2026 (1)

DOI: 10.1155/jdr/4391252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, online erschienen am 03.05.2026. Verfasst von Yuxin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China, cpu.edu.cn. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Toll-Like Receptor 4, NF-kappa B. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Qiling Hushen Formula (QLHSF) has been widely used in clinical treatment for Type 2 diabetic kidney disease (T2DKD), yet its mechanism remains unclear.

Objective

This study is aimed at elucidating the protective effects and mechanisms of QLHSF on T2DKD mice.

Methods

Chemical components of QLHSF were analyzed via ultraperformance liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometry (UPLC‐QTOF‐MS/MS). After 6 weeks of QLHSF intervention in C57BL/KSJ db/db mice, urine and serum samples were collected to measure biochemical parameters, inflammatory cytokines, and lipopolysaccharide (LPS) levels. Renal and colonic tissues were sectioned and subjected to histopathological staining. To evaluate the diversity and abundance of the gut microbiota, its composition was determined through 16S rRNA gene sequencing. Expression levels of colonic tight junction proteins, along with key proteins involved in the renal TLR4/NF‐ κ B signaling pathway and NLRP3 inflammasome activation, were measured.

Results

QLHSF decreased proteinuria and improved renal function in T2DKD mice. Renal pathological injuries and intestinal barrier destruction were also alleviated. Analysis of 16S rRNA sequencing data demonstrated that QLHSF significantly modulated the gut microbiota composition, enriching beneficial bacteria such as g_Bacteroides , g_Lachnospiraceae_NK4A136_group , g_Alistipes , g_Muribaculum , g_Odoribacter , and g_Lachnoclostridium . QLHSF treatment led to a reduction in serum LPS levels and inhibition of the renal TLR4/NF‐ κ B/NLRP3 signaling pathway, leading to reduced inflammatory cytokine production.

Conclusions

In T2DKD mice, QLHSF ameliorated proteinuria and renal injury through modulation of the gut microbiota, preservation of intestinal barrier integrity, and inhibition of the renal TLR4/NF‐ κ B/NLRP3 pathway. These findings elucidate the pharmacological mechanism of QLHSF and provide strong experimental support for its clinical application in the treatment of T2DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NephropathiesToll-Like Receptor 4NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinGastrointestinal MicrobiomeKidneyDrugs, Chinese HerbalAnimalsMiceDiabetes Mellitus, ExperimentalChromatography, LiquidTandem Mass SpectrometryMice, Inbred C57BLProteinuriaIntestinal Barrier FunctionCytokinesRNA, Ribosomal, 16SBacteriaMaleColonLipopolysaccharides

Stichwörter der Autor:innen

Qiling Hushen FormulaTLR4/NF-κB/NLRP3 signaling pathwayType 2 diabetic kidney diseasegut microbiotagut-kidney axisintestinal barrier

Substanzen

Tlr4 protein, mouseToll-Like Receptor 4NF-kappa BNlrp3 protein, mouseNLR Family, Pyrin Domain-Containing 3 ProteinCytokinesDrugs, Chinese HerbalRNA, Ribosomal, 16SLipopolysaccharides

Autor:innen und Institutionen

  • School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China, cpu.edu.cn.
  • Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China, njucm.edu.cn.
  • New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China, cpu.edu.cn.

ORCID-Profile: Yuxin Wang, Pei Sheng, Xue Wang, Min Lin, Wentao Cai, Shiyao Wei, Yuyun Du, Ming Yan, Lei Wang, Xiaofei An

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Sheng, P., Wang, X., Lin, M., Cai, W., Wei, S., Du, Y., Yan, M., Wang, L., & An, X. (2026). Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut‐Kidney Axis Restoration and TLR4/NF‐ κ B/NLRP3 Suppression. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/4391252

Vancouver

Wang Y, Sheng P, Wang X, Lin M, Cai W, Wei S, et al. Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut‐Kidney Axis Restoration and TLR4/NF‐ κ B/NLRP3 Suppression. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/4391252

BibTeX
@article{Wang2026,
  author = {Wang, Yuxin and Sheng, Pei and Wang, Xue and Lin, Min and Cai, Wentao and Wei, Shiyao and Du, Yuyun and Yan, Ming and Wang, Lei and An, Xiaofei},
  title = {Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut‐Kidney Axis Restoration and TLR4/NF‐ κ B/NLRP3 Suppression},
  journal = {Journal of Diabetes Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jdr/4391252}
}
Kostenlos starten →